Rasagiline
- Generic Name
- Rasagiline
- Brand Names
- Azilect, Rasagiline Mylan, Rasagiline ratiopharm
- Drug Type
- Small Molecule
- Chemical Formula
- C12H13N
- CAS Number
- 136236-51-6
- Unique Ingredient Identifier
- 003N66TS6T
- Background
Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
- Indication
For the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa.
- Associated Conditions
- Parkinson's Disease (PD)
- Associated Therapies
- -
NT-0796: A Clinical CNS-Active NLRP3 Inhibitor Prodrug with Anti-Neuroinflammatory Activity
Nuvalent's NVL-520, an oral, brain-penetrant, TRK-sparing ROS1 kinase inhibitor, entered Ph. II of ARROS-1 trial for advanced ROS1-positive NSCLC, showcasing a potential best-in-class profile.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath